These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 18886)

  • 1. Effects of 5,6-dihydroxytryptamine on tyrosine-hydroxylase activity in central catecholaminergic neurons of the rat.
    Renaud B; Buda M; Lewis BD; Pujol JF
    Biochem Pharmacol; 1975 Sep; 24(18):1739-42. PubMed ID: 17
    [No Abstract]   [Full Text] [Related]  

  • 2. Regional and ultrastructural localization of tyrosine hydroxylass by immunocytochemistry in dopaminergic neurons of the mesolimbic and nigroneostriatal systems.
    Pickel VM; Joh TH; Reis DJ
    Adv Biochem Psychopharmacol; 1977; 16():321-9. PubMed ID: 18885
    [No Abstract]   [Full Text] [Related]  

  • 3. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C; Kirik D; Björklund A
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of reserpine on activities and amounts of tyrosine hydroxylase and dopamine-beta-hydroxylase in catecholamine neuronal systems in rat brain.
    Reis DJ; Joh TH; Ross RA
    J Pharmacol Exp Ther; 1975 Jun; 193(3):775-84. PubMed ID: 239215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic treatment with neuroleptics: similarities and differences in their action on nigrostriatal, mesolimbic, and mesocortical dopaminergic neurons.
    Julou L; Scatton B; Glowinski J
    Adv Biochem Psychopharmacol; 1977; 16():617-24. PubMed ID: 18904
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversible changes in the activities and amounts of tyrosine hydroxylase in dopamine neurons of the substantia nigra in response to axonal injury as studied by immunochemical and immunocytochemical methods.
    Reis DJ; Gilad G; Pickel VM; Joh TH
    Brain Res; 1978 Apr; 144(2):325-42. PubMed ID: 25123
    [No Abstract]   [Full Text] [Related]  

  • 7. Dynamic changes in the activities and amounts of neurotransmitter-synthesizing enzymes in mesolimbic and other central catecholamine neurons in response to axonal injury and during collateral sprouting.
    Reis DJ; Gilad GM; Pickel VM; Ross RA; Joh TH
    Adv Biochem Psychopharmacol; 1977; 16():331-41. PubMed ID: 18886
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroanatomical and neurochemical substrate of pleasure.
    Cytawa J; Trojniar W
    Acta Physiol Pol; 1980; 31 Suppl 20():85-106. PubMed ID: 6105761
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurotransmitter synthetic enzymes.
    McGeer PL; McGeer EG
    Prog Neurobiol; 1973; 2(1):69-117. PubMed ID: 4149290
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of carotid body catecholamines in chemoreceptor function.
    Mills E; Smith PG; Slotkin TA; Breese G
    Neuroscience; 1978; 3(12):1137-46. PubMed ID: 33349
    [No Abstract]   [Full Text] [Related]  

  • 11. Tyrosine hydroxylase regulation in the central nervous system.
    Masserano JM; Weiner N
    Mol Cell Biochem; 1983; 53-54(1-2):129-52. PubMed ID: 6137760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of protein phosphorylation in regulation of neurotransmitter biosynthesis].
    Okuno S; Fujisawa H
    Seikagaku; 1984 Nov; 56(11):1380-9. PubMed ID: 6151961
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.